Workflow
鱼子气垫
icon
Search documents
毛戈平(01318):财报点评:业绩如期兑现,大单品矩阵持续丰富
East Money Securities· 2026-03-31 07:57
Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market index [4]. Core Insights - The company achieved a revenue of 5.05 billion RMB in 2025, representing a year-over-year growth of 30.0%, with a net profit of 1.21 billion RMB, up 36.8% year-over-year [1]. - The growth in revenue and net profit is attributed to the successful performance of major product categories, including cosmetics and skincare, with several products exceeding 1 billion RMB in sales [7]. - The company is expected to continue its growth trajectory, with projected net profits of 1.59 billion RMB, 1.99 billion RMB, and 2.42 billion RMB for 2026, 2027, and 2028, respectively, reflecting growth rates of 32%, 25%, and 22% [7]. Revenue Breakdown - **Cosmetics**: In 2025, revenue reached 3.0 billion RMB, with a year-over-year growth of 30.0%. The average selling price decreased by 1%, while the volume increased by 31% [2]. - **Skincare**: Revenue for skincare products was 1.87 billion RMB, growing by 31.1% year-over-year, with significant contributions from star products [2]. - **Fragrance**: The fragrance segment generated 34 million RMB in its first year, indicating potential for brand development [2]. - **Training Business**: This segment saw a slight decline, with revenue of 150 million RMB, down 2.8% year-over-year [2]. Channel Performance - **Online Channels**: Revenue from online sales was 2.48 billion RMB, reflecting a year-over-year increase of 38.8%, with a customer repurchase rate of 30.3% [6]. - **Offline Channels**: Offline sales reached 2.43 billion RMB, up 24.5% year-over-year, with a repurchase rate of 36.5% [6]. Financial Metrics - The company’s gross margin for 2025 was 84.2%, with a net profit margin of 23.9%, indicating stable profitability [6]. - The projected earnings per share (EPS) for 2026 is 3.24 RMB, with a price-to-earnings (P/E) ratio of 21.14 [8].
毛戈平(01318):高端美妆壁垒稳固,全链路效率持续优化
Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the near term [8]. Core Insights - The company has demonstrated strong financial performance, with 2025 revenue reaching 5.05 billion RMB, a year-on-year increase of 30%, and net profit of 1.205 billion RMB, up 36.8% [8]. - The company's gross margin stands at 84.22%, with a net profit margin of 23.87%, significantly exceeding industry averages, showcasing its robust profitability [8]. - The company is focusing on optimizing its product categories, with significant growth in both makeup and skincare segments, and has recently entered the fragrance market, indicating a comprehensive product strategy [8]. - The company is expanding its high-end market presence, with a balanced approach between online and offline sales channels, and plans to enhance its store coverage in high-tier cities and explore international markets [8]. Financial Data and Profit Forecast - Projected revenue growth from 2024 to 2028 is as follows: 3.885 billion RMB in 2024, 5.050 billion RMB in 2025, 6.575 billion RMB in 2026, 8.189 billion RMB in 2027, and 10.199 billion RMB in 2028, with a compound annual growth rate (CAGR) of approximately 25% [7][9]. - The forecasted net profit for the same period is expected to be 881 million RMB in 2024, 1.205 billion RMB in 2025, 1.560 billion RMB in 2026, 1.954 billion RMB in 2027, and 2.289 billion RMB in 2028, reflecting a strong growth trajectory [7][9]. - The earnings per share (EPS) is projected to increase from 2.18 RMB in 2024 to 4.67 RMB in 2028, indicating a solid return for shareholders [7].
毛戈平20260329
2026-03-30 05:15
Summary of the Conference Call for Mao Geping Company Company Overview - **Company**: Mao Geping - **Industry**: Cosmetics and Skincare Key Financial Performance and Profitability - **2025 Revenue**: 50.5 billion CNY, a year-on-year increase of 30% [3] - **Net Profit**: 12.1 billion CNY, a year-on-year increase of 37% [3] - **Net Profit Margin**: Increased by 1.2 percentage points to 23.9% [3] - **Gross Margin**: 84.2%, a slight decrease of 0.2 percentage points from 2024 [3] - **Gross Margin by Category**: Skincare at 87.3%, Makeup at 83.3% [3] - **Sales Expense Ratio**: 48.3%, down by 0.7 percentage points [3] - **Management Expense Ratio**: 5.3%, down by 1.6 percentage points [3] Revenue Breakdown by Category - **Makeup Revenue**: 30 billion CNY, a year-on-year increase of 30%, accounting for 59% of total revenue [4] - **Top Products**: Caviar Cushion (over 5 billion CNY), Gold Fan Powder, Skin Garment (both over 3 billion CNY) [4] - **Skincare Revenue**: 18.7 billion CNY, a year-on-year increase of 31%, accounting for 37% of total revenue [4] - **Top Products**: Luxury Caviar Mask (over 10 billion CNY), Black Cream (over 4 billion CNY), Caviar Eye Mask (around 1 billion CNY) [4] - **Fragrance Revenue**: New category launched in May 2025, contributing approximately 34 million CNY by year-end [4] Channel Performance - **Online Revenue**: 24.8 billion CNY, a year-on-year increase of 39%, with a net profit margin of 26.2% [5] - **Offline Revenue**: 24.3 billion CNY, a year-on-year increase of 24.5%, with a net profit margin of 21.6% [5] - **Store Expansion**: 36 new offline stores added in 2025, with same-store sales growth of 16% [5] - **Customer Retention**: Repeat purchase rate increased to 36.5% [5] Future Growth Guidance - **2026 Revenue Target**: Maintain over 30% growth, with net profit growth slightly exceeding revenue growth [6] - **Makeup Strategy**: Focus on core products and new launches, with significant growth potential in color cosmetics [6] - **Skincare Focus**: Emphasis on daily skincare lines, with six major series launched [7] - **Fragrance Strategy**: Plans to expand in the domestic perfume market, leveraging brand storytelling [7] Expansion Plans - **Offline Store Growth**: Plan to add approximately 30 new stores in 2026, focusing on high-end malls and airports [8] - **Same-Store Growth Target**: Maintain at least 12% growth [8] - **International Expansion**: Targeting top luxury malls abroad, leveraging partnerships for high-end retail access [8] Valuation and Market Outlook - **2026 Net Profit Estimate**: Approximately 16 billion CNY, corresponding to a PE ratio of about 19 times [9] - **Investment Thesis**: Considered a high-end domestic brand with attractive valuation and growth potential [9]
毛戈平:2025业绩符合预期,管理层维持30%增长指引-20260330
海通国际· 2026-03-30 00:25
Investment Rating - The report maintains an "Outperform" rating for Mao Geping Cosmetics [2][3]. Core Insights - The company achieved a revenue of RMB 5.05 billion in 2025, reflecting a year-on-year growth of 30%, and net profit attributable to the parent was RMB 1.20 billion, up 36.7% year-on-year [4][12]. - Management has set a growth guidance of 30% for the upcoming years, with expectations for revenue to reach RMB 6.50 billion, RMB 8.15 billion, and RMB 9.97 billion in 2026, 2027, and 2028, respectively [3][11]. - The company’s net profit margins are projected to remain robust at 23.3%, 22.9%, and 22.7% for the years 2026 to 2028 [11]. Financial Performance - Revenue for 2025 was RMB 5.05 billion, slightly below expectations by 1.0%, while net profit exceeded expectations by 0.2% [4][12]. - The gross profit margin for 2025 was reported at 84.2%, which is an improvement of 0.3 percentage points compared to expectations [8]. - The company’s diluted EPS for 2025 was RMB 2.46, with a projected increase to RMB 3.09 in 2026 [2][10]. Product Performance - Key products such as the Luxury Caviar Cushion and the Luxury Caviar Mask have shown strong sales, contributing significantly to revenue [5][13]. - The color cosmetics segment generated RMB 3.00 billion in revenue for 2025, while skincare revenue reached RMB 1.87 billion, both showing substantial year-on-year growth [14][15]. - New product launches in 2026 are expected to further enhance sales, particularly in the skincare and eye makeup categories [5][13]. Market Position and Strategy - The company has successfully increased its online sales, which accounted for over 50% of total revenue for the first time, with a year-on-year growth of 38.8% [6][15]. - Offline same-store sales grew by 16%, indicating strong brand loyalty and customer retention [6][15]. - Mao Geping Cosmetics aims to continue expanding its high-end market presence while maintaining a clear strategy focused on online customer acquisition and premium product offerings [14][15].
毛戈平(01318):2025业绩符合预期,管理层维持30%增长指引
Investment Rating - The report maintains an "Outperform" rating for Mao Geping Cosmetics [2][3]. Core Insights - The company achieved a revenue of RMB 5.05 billion in 2025, reflecting a year-on-year growth of 30%, and net profit attributable to the parent was RMB 1.20 billion, up 36.7% year-on-year [4][12]. - Management has set a growth guidance of 30% for the upcoming years, with expectations for revenue to reach RMB 6.50 billion, RMB 8.15 billion, and RMB 9.97 billion in 2026, 2027, and 2028, respectively [3][11]. - The company has demonstrated strong performance in its core product lines, with significant contributions from new product launches in both color cosmetics and skincare [5][13]. Financial Performance - For 2025, the company reported a gross profit margin of 84.2% and a net profit margin of 23.8% [4][12]. - The projected net profit for 2026 is RMB 1.52 billion, with a net profit margin of 23.3%, and is expected to grow at a rate of 25.8% year-on-year [3][11]. - The company’s revenue growth is expected to slow slightly to 28.7% in 2026, 25.4% in 2027, and 22.4% in 2028 [3][11]. Product Performance - Key products such as the Luxury Caviar Cushion and the Luxury Caviar Mask have shown strong sales, contributing significantly to the overall revenue [5][13]. - The color cosmetics segment generated RMB 3.00 billion in revenue for 2025, while skincare revenue reached RMB 1.87 billion, indicating robust growth in both categories [14][15]. Market Position and Strategy - The company has successfully increased its online sales, which accounted for over 50% of total revenue for the first time, with a year-on-year growth of 38.8% [6][15]. - Mao Geping Cosmetics plans to continue expanding its high-end product lines and enhance its online presence to attract more customers [5][14].
商贸零售行业周报:业绩密集披露,关注赛道景气验证和高增长标的-20260329
KAIYUAN SECURITIES· 2026-03-29 11:13
Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights a significant performance disclosure period for listed companies, focusing on high-growth sectors such as gold and jewelry, cosmetics, and medical aesthetics, with a notable divergence in performance among consumer brands [4][25] - High-end domestic brands like Laopuhuangjin and Maogeping are showing strong growth, while brands that adapt to channel changes and possess differentiated product capabilities, such as Chaohongji and Shangmei, are also performing well [4][25] Summary by Sections Retail and Social Services Market Review - The retail and social services indices reported declines of 1.10% and 1.52% respectively during the week of March 23-27, 2026, ranking 19th and 24th among 31 primary industries [6][14] - The jewelry sector saw the highest weekly increase of 1.05%, while the hotel and restaurant sector led year-to-date performance with a 0.77% increase [18][20] Industry Dynamics - The report emphasizes the ongoing annual report disclosures from listed companies, with a focus on high-growth companies [25] - The gold and jewelry sector continues to show a trend towards high-end and fashionable products, with Laopuhuangjin and Chaohongji demonstrating exceptional performance [28][39] Investment Recommendations - Investment focus areas include: - Gold and jewelry brands with differentiated product capabilities, recommending Laopuhuangjin, Chaohongji, and Zhou Dafu [7][42] - Offline retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Jihong Co [7][39] - Cosmetics brands that meet emotional value and safety innovation, recommending Maogeping, Shangmei, and Beitaini [7][40] - Medical aesthetics firms with differentiated products and expanding chains, recommending Aimeike and Meilitiantian Medical Health [7][41] Company-Specific Insights - Laopuhuangjin reported a revenue of 27.303 billion yuan (+221.0%) and a net profit of 4.868 billion yuan (+230.5%) for FY2025, with expectations for continued growth in Q1 2026 [28][41] - Chaohongji achieved a revenue of 9.318 billion yuan (+43.0%) and a net profit of 497 million yuan (+156.7%) for FY2025, with rapid growth in its franchise business [45][46] - Maogeping's revenue reached 5.050 billion yuan (+30.0%) with a net profit of 1.205 billion yuan (+36.8%) for FY2025, showcasing strong performance in high-end channels [32][41] - Shangmei reported a revenue of 9.178 billion yuan (+35.1%) and a net profit of 1.103 billion yuan (+41.1%) for FY2025, with a focus on multi-category growth [32][41]
毛戈平(01318):业绩符合预期,坚定长期主义与品牌价值
GF SECURITIES· 2026-03-29 09:48
Investment Rating - The report assigns a "Buy" rating for the company, with a current price of 74.35 HKD and a target value of 104.46 HKD [3]. Core Insights - The company's performance in 2025 met expectations, achieving a revenue of 5.05 billion RMB, a 30% year-on-year increase, and a net profit of 1.20 billion RMB, up 37% year-on-year. The gross margin remained stable at a high level of 84.2% [8]. - The company is focused on long-term brand value and has shown strong sales performance across all channels, supported by a solid brand reputation and strategic partnerships, including backing from LVMH [8]. - The company is expected to achieve a net profit of 1.57 billion RMB in 2026, maintaining a reasonable value of 104.46 HKD per share [8]. Financial Performance Summary - **Revenue Forecast**: - 2024A: 3.885 billion RMB - 2025A: 5.050 billion RMB - 2026E: 6.450 billion RMB - 2027E: 8.111 billion RMB - 2028E: 10.041 billion RMB - Growth rates: 34.6% (2024A), 30.0% (2025A), 27.7% (2026E), 25.8% (2027E), 23.8% (2028E) [8][11]. - **Profitability Metrics**: - EBITDA: - 2024A: 1.261 billion RMB - 2025A: 1.700 billion RMB - 2026E: 2.180 billion RMB - 2027E: 2.730 billion RMB - 2028E: 3.358 billion RMB [8]. - Net Profit: - 2024A: 881 million RMB - 2025A: 1.204 billion RMB - 2026E: 1.572 billion RMB - 2027E: 1.983 billion RMB - 2028E: 2.446 billion RMB [8]. - **Valuation Ratios**: - P/E Ratio: - 2024A: 28.7 - 2025A: 29.4 - 2026E: 20.5 - 2027E: 16.2 - 2028E: 13.2 [8]. - ROE: - 2024A: 25.2% - 2025A: 25.8% - 2026E: 28.4% - 2027E: 29.9% - 2028E: 30.7% [8].
毛戈平:港股公司信息更新报告:2025年业绩亮眼,多品类协同品牌势能高位延续-20260327
KAIYUAN SECURITIES· 2026-03-27 08:24
Investment Rating - The investment rating for the company is "Buy" (maintained) [1][11] Core Insights - The company reported a revenue increase of 30.0% year-on-year for 2025, reaching 5.05 billion yuan, and a net profit increase of 36.8%, amounting to 1.205 billion yuan. The brand's momentum continues to be strong, leading to an upward revision of profit forecasts for 2026-2028 [4][5] - The company expects net profits for 2026, 2027, and 2028 to be 1.587 billion, 1.978 billion, and 2.457 billion yuan respectively, with corresponding EPS of 3.24, 4.04, and 5.01 yuan. The current stock price corresponds to P/E ratios of 19.0, 15.2, and 12.2 for the respective years [4][7] Financial Performance - In 2025, the company's revenue from different segments was as follows: makeup 2.996 billion yuan (up 30.0%), skincare 1.873 billion yuan (up 31.1%), and training 147 million yuan (down 2.8%). The newly added fragrance segment generated 34 million yuan [5] - The online and offline channels generated revenues of 2.477 billion and 2.426 billion yuan respectively, with year-on-year growth of 38.8% and 24.5% [5] - The gross profit margin for 2025 was 84.2%, with slight decreases in various segments, while the overall expense ratios for sales and management showed a steady decline [5][7] Business Development - The company continues to strengthen its high-end positioning with successful product launches in the makeup and skincare segments, including significant sales from key products [6] - The company has expanded its presence in high-end retail locations and online platforms, achieving notable sales growth in e-commerce channels [6]
毛戈平(01318):港股公司信息更新报告:2025年业绩亮眼,多品类协同品牌势能高位延续
KAIYUAN SECURITIES· 2026-03-27 07:35
Investment Rating - The investment rating for the company is "Buy" (maintained) [1][11] Core Insights - The company reported a revenue increase of 30.0% year-on-year for 2025, reaching 5.05 billion yuan, and a net profit increase of 36.8%, amounting to 1.205 billion yuan. The brand's momentum continues to be strong, leading to an upward revision of profit forecasts for 2026-2028 [4][5] - The company expects net profits for 2026, 2027, and 2028 to be 1.587 billion, 1.978 billion, and 2.457 billion yuan respectively, with corresponding EPS of 3.24, 4.04, and 5.01 yuan. The current stock price corresponds to P/E ratios of 19.0, 15.2, and 12.2 for the respective years [4][7] Financial Performance - In 2025, the revenue breakdown by business segment was as follows: makeup 2.996 billion yuan (up 30.0%), skincare 1.873 billion yuan (up 31.1%), and makeup training 147 million yuan (down 2.8%). The newly added fragrance segment generated 34 million yuan [5] - Revenue from online and offline channels reached 2.477 billion and 2.426 billion yuan respectively, with year-on-year growth of 38.8% and 24.5% [5] - The gross margin for 2025 was 84.2%, with slight decreases in various segments, while the overall expense ratios for sales and management decreased to 48.3% and 5.3% respectively [5] Business Development - The company has solidified its leading position in high-end domestic makeup, with significant sales from key products such as the small gold fan powder and caviar cushion, each exceeding 300 million yuan. The skincare segment also saw strong performance with flagship products achieving over 1 billion yuan in retail sales [6] - The company is expanding its high-end channel presence and has opened new stores in prestigious locations, enhancing its brand positioning. The online sales channels are also performing well, with significant growth expected to continue [6]
商贸零售行业周报:老铺黄金调价幅度超预期,巩固品牌高端调性-20260301
KAIYUAN SECURITIES· 2026-03-01 07:58
Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights that the price adjustment by Laopu Gold exceeded expectations, reinforcing its high-end brand positioning. The price increase for most products ranged from 20% to 30%, significantly higher than previous adjustments [5][27] - The report emphasizes the shift in consumer demand towards self-wearing and aesthetic-driven purchases, suggesting that brands with differentiated product offerings are likely to navigate price increases more smoothly [31] Summary by Sections Industry Trends - The retail and social service indices reported a decline of 1.64% and an increase of 1.68% respectively during the week from February 24 to February 27, 2026. The retail index ranked 30th among 31 primary industries [7][16] - The jewelry sector has shown the highest growth, with a year-to-date increase of 10.59% [19] Investment Recommendations - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending Laopu Gold and Chaohongji, with beneficiaries including Liu Fu Group and Zhou Shengsheng [8][33] - Investment Theme 2: Highlighting retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Aiyingshi [8][33] - Investment Theme 3: Emphasizing beauty brands that meet emotional value and safety ingredient innovation, recommending Maogeping and Pola [8][33] - Investment Theme 4: Focusing on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending Meilitiantian Medical Health and Aimeike [8][33] Company-Specific Insights - Laopu Gold reported a revenue of 12.354 billion yuan for the first half of FY2025, a year-on-year increase of 250.9%, with a net profit of 2.268 billion yuan, up 285.8% [35] - Chaohongji is expected to achieve a net profit of 436 to 533 million yuan in 2025, reflecting a growth of 125% to 175% [35] - Yonghui Supermarket is projected to have a net profit of -2.14 billion yuan in 2025, indicating a significant operational challenge [35] - Meilitiantian Medical Health anticipates a net profit growth of no less than 34% in 2025, showcasing strong resilience and potential for growth [43]